1. Home
  2. TMDX vs TNL Comparison

TMDX vs TNL Comparison

Compare TMDX & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • TNL
  • Stock Information
  • Founded
  • TMDX 1998
  • TNL 1990
  • Country
  • TMDX United States
  • TNL United States
  • Employees
  • TMDX N/A
  • TNL N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TNL Hotels/Resorts
  • Sector
  • TMDX Health Care
  • TNL Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • TNL Nasdaq
  • Market Cap
  • TMDX 4.0B
  • TNL 3.3B
  • IPO Year
  • TMDX 2019
  • TNL N/A
  • Fundamental
  • Price
  • TMDX $130.67
  • TNL $65.22
  • Analyst Decision
  • TMDX Buy
  • TNL Buy
  • Analyst Count
  • TMDX 12
  • TNL 10
  • Target Price
  • TMDX $128.92
  • TNL $66.90
  • AVG Volume (30 Days)
  • TMDX 868.2K
  • TNL 739.4K
  • Earning Date
  • TMDX 10-29-2025
  • TNL 10-22-2025
  • Dividend Yield
  • TMDX N/A
  • TNL 3.44%
  • EPS Growth
  • TMDX 2163.11
  • TNL 3.11
  • EPS
  • TMDX 2.02
  • TNL 6.07
  • Revenue
  • TMDX $531,292,000.00
  • TNL $3,967,000,000.00
  • Revenue This Year
  • TMDX $38.78
  • TNL $4.11
  • Revenue Next Year
  • TMDX $20.76
  • TNL $4.25
  • P/E Ratio
  • TMDX $64.68
  • TNL $10.77
  • Revenue Growth
  • TMDX 48.09
  • TNL 3.60
  • 52 Week Low
  • TMDX $55.00
  • TNL $37.77
  • 52 Week High
  • TMDX $145.50
  • TNL $70.43
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 69.28
  • TNL 59.33
  • Support Level
  • TMDX $108.34
  • TNL $59.45
  • Resistance Level
  • TMDX $118.51
  • TNL $70.43
  • Average True Range (ATR)
  • TMDX 6.15
  • TNL 2.27
  • MACD
  • TMDX 1.78
  • TNL 0.67
  • Stochastic Oscillator
  • TMDX 86.45
  • TNL 56.40

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: